Last updated: June 4, 2026
Tri-Estarylla is a combined oral contraceptive (COC) containing ethinyl estradiol (EE) and norgestimate. Public supplier visibility for this product is primarily mediated through FDA labeling, distributor channels, and the Orange Book listing of the reference product and its applicants for listed patents. A complete, accurate “who supplies what” map for tri-estarylla (API makers, finished-dose manufacturers, and excipient/package suppliers) cannot be produced from the available information in this feed.
What suppliers make Tri-Estarylla tablets for the U.S. market?
No complete manufacturer-of-record list for finished-dose Tri-Estarylla tablets is available in the provided information.
Which companies are listed as applicants or manufacturers in FDA product listings?
No applicant/manufacturer entities for Tri-Estarylla are available in the provided information.
Are there multiple finished-dose sources (site-level supply risk)?
No site-level multiplicity information is available in the provided information.
Which companies supply the ethinyl estradiol and norgestimate active pharmaceutical ingredients (APIs) used in Tri-Estarylla?
No API supplier roster for ethinyl estradiol or norgestimate used in Tri-Estarylla is available in the provided information.
Are the APIs sourced from common upstream vendors used across norgestimate COCs?
No cross-product supply-chain linkage is available in the provided information.
What forms are typically used (e.g., micronized vs. specific crystal forms)?
No material- or solid-state-specification supplier data is available in the provided information.
What excipients and packaging components are required for Tri-Estarylla and who supplies them?
No excipient or packaging supplier list for Tri-Estarylla is available in the provided information.
Do packaging formats (blisters vs bottles) drive different suppliers?
No packaging configuration for Tri-Estarylla is available in the provided information.
What is the Orange Book status of Tri-Estarylla, and does it constrain supplier options?
No Orange Book listing data for Tri-Estarylla is available in the provided information.
How does patent and exclusivity status affect generic and CMO supply?
No exclusivity or patent-status information is available in the provided information.
How does Tri-Estarylla supply compare with other norgestimate/ethinyl estradiol COCs (e.g., Sprintec, Ortho-Cyclen equivalents)?
No comparative supply-chain or manufacturer overlap data is available in the provided information.
Are there shared contract manufacturers across these brands?
No shared-manufacturer information is available in the provided information.
What generic entry risks exist for Tri-Estarylla based on supplier readiness?
No Paragraph IV, ANDA status, or supplier-readiness signals for Tri-Estarylla are available in the provided information.
Do manufacturing/IP barriers affect the number of qualified suppliers?
No manufacturing or IP barrier data is available in the provided information.
Key Takeaways
- A complete, accurate supplier mapping for Tri-Estarylla is not available from the provided information.
- No validated list of finished-dose manufacturers, API suppliers for ethinyl estradiol and norgestimate, or excipient/packaging suppliers can be produced here without FDA/Orange Book product listing details and associated documentation.
FAQs
-
Who is the manufacturer of record for Tri-Estarylla tablets in the U.S.?
Not provided in the available information.
-
Which companies produce the ethinyl estradiol and norgestimate APIs for Tri-Estarylla?
Not provided in the available information.
-
Are there multiple CMO or plant sites for Tri-Estarylla supply?
Not provided in the available information.
-
Does Tri-Estarylla have Orange Book-listed patents that limit generic sourcing?
Not provided in the available information.
-
Do packaging format choices for Tri-Estarylla change the supplier set?
Not provided in the available information.
References
- FDA Orange Book database (access required for Tri-Estarylla entries).
- FDA Drug Labeling for Tri-Estarylla (package insert and prescribing information, manufacturer/distributor sections).
